STANDSTILL AGREEMENTStandstill Agreement • January 29th, 2024 • Vitro Biopharma, Inc. • Biological products, (no disgnostic substances)
Contract Type FiledJanuary 29th, 2024 Company IndustryThis Standstill Agreement (“Agreement”) is entered into and effective this 20th day of November 2022 (“Effective Date”) by and between Jack Zamora, M.D., an individual (“Zamora”) with an address of [***], and Vitro Biopharma, Inc., a Nevada corporation (“Vitro”) with its principal place of business located at 4621 Technology Drive, Golden, CO 80122. Zamora or Vitro may sometimes be referred to as a “Party” and collectively as the “Parties.”
STANDSTILL AGREEMENTStandstill Agreement • January 30th, 2023 • Vitro Biopharma, Inc. • Biological products, (no disgnostic substances)
Contract Type FiledJanuary 30th, 2023 Company IndustryThis Standstill Agreement (“Agreement”) is entered into and effective this 20th day of November 2022 (“Effective Date”) by and between Jack Zamora, M.D., an individual (“Zamora”) with an address of [***], and Vitro Biopharma, Inc., a Nevada corporation (“Vitro”) with its principal place of business located at 4621 Technology Drive, Golden, CO 80122. Zamora or Vitro may sometimes be referred to as a “Party” and collectively as the “Parties.”
STANDSTILL AGREEMENTStandstill Agreement • December 2nd, 2022 • Furman Christopher • Biological products, (no disgnostic substances) • Nevada
Contract Type FiledDecember 2nd, 2022 Company Industry JurisdictionThis Standstill Agreement (“Agreement”) is entered into and effective this 20th day of November 2022 (“Effective Date”) by and between Jack Zamora, M.D., an individual (“Zamora”) with an address of [***], and Vitro Biopharma, Inc., a Nevada corporation (“Vitro”) with its principal place of business located at 4621 Technology Drive, Golden, CO 80122. Zamora or Vitro may sometimes be referred to as a “Party” and collectively as the “Parties.”